|
|
Vaccine Detail
|
IIBR-100 |
| Vaccine Information |
- Vaccine Name: IIBR-100
- Target Pathogen: SARS-CoV-2
- Target Disease: COVID-19
- Manufacturer: Israel Institute for Biological Research, Weizmann Institute of Science
- Vaccine Ontology ID: VO_0005090
- Type: Recombinant vector vaccine
- Status: Clinical trial
- Host Species for Licensed Use: Human
- Immunization Route: Intramuscular injection (i.m.)
|
| Host Response |
|
|
| References |
|
|
|
